Patent classifications
C01F17/30
SODIUM ANTI-PEROVSKITE SOLID ELECTROLYTE COMPOSITIONS
Na-rich electrolyte compositions provided herein can be used in a variety of devices, such as sodium ionic batteries, capacitors and other electrochemical devices. Na-rich electrolyte compositions provided herein can have a chemical formula of Na.sub.3OX, Na.sub.3SX, Na .sub.(3-δ) M.sub.δ/2OX and Na .sub.(3-δ) M.sub.δ/2SX wherein 0<δ<0.8, wherein X is a monovalent anion selected from fluoride, chloride, bromide, iodide, H.sup.−, CN.sup.−, BF.sub.4.sup.−, BH.sub.4.sup.−, ClO.sub.4.sup.−, CH.sub.3.sup.−, NO.sub.2.sup.−, NH.sub.2.sup.− and mixtures thereof, and wherein M is a divalent metal selected from the group consisting of magnesium, calcium, barium, strontium and mixtures thereof. Na-rich electrolyte compositions provided herein can have a chemical formula of Na .sub.(3-δ) M.sub.δ/3OX and/or Na .sub.(3-δ) M.sub.δ/3SX; wherein 0<δ<0.5, wherein M is a trivalent cation M.sup.3, and wherein X is selected from fluoride, chloride, bromide, iodide, H.sup.−, CN.sup.−, BF.sub.4.sup.−, BH.sub.4.sup.−, ClO.sub.4.sup.−, CH.sub.3.sup.−, NO.sub.2.sup.−, NH.sup.2− and mixtures thereof. Synthesis and processing methods of NaRAP compositions for battery, capacitor, and other electrochemical applications are also provided.
COMPOUND SEMICONDUCTOR AND MANUFACTURING METHOD THEREOF
Disclosed is a compound semiconductor material with excellent performance and its utilization. The compound semiconductor may be expressed by Chemical Formula 1 below:
M1.sub.aCo.sub.4Sb.sub.12-xM2.sub.x Chemical Formula 1
where M1 and M2 are respectively at least one selected from In and a rare earth metal element, 0≦a≦1.8, and 0≦x≦0.6.
WAVELENGTH CONVERSION MATERIAL AND MANUFACTURING METHOD THEREOF, WAVELENGTH CONVERSION DEVICE, AND PROJECTION DEVICE
A wavelength conversion material and a manufacturing method thereof, a wavelength conversion device, and a projection device are provided. The wavelength conversion material has higher phosphor conversion efficiency. The wavelength conversion material includes a first phase. A composition of the first phase is M.sub.3Al.sub.5(O.sub.1-0.5xF.sub.x).sub.12:Ce.sup.3+, where M is at least one selected from a group consisting of yttrium (Y), lutetium (Lu), gadolinium (Gd), terbium (Tb), praseodymium (Pr), and neodymium (Nd), and 0.012≤x≤0.3. The wavelength conversion material with good phosphor conversion efficiency is provided.
Nitride Luminescent Material and Light Emitting Device Comprising Same
The present disclosure relates to the technical field of luminescent materials, and more particularly, to a nitride luminescent material and a light emitting device comprising the luminescent material. The nitride luminescent material recited in the present disclosure includes an inorganic compound with the structural composition R.sub.wQ.sub.xSi.sub.yN.sub.z, the excitation wavelength of the luminescent material is between 300-650 nm, and the emission main peak of the NIR light region is broadband emission between 900-1100 nm; the excitation wavelength of the luminescent material is relatively broad and capable of excellent absorption of ultraviolet visible light, and has more intensive NIR emission as compared with NIR organic luminescent materials and inorganic luminescent materials of other systems, so it is an ideal application material for NIR devices.
Nitride Luminescent Material and Light Emitting Device Comprising Same
The present disclosure relates to the technical field of luminescent materials, and more particularly, to a nitride luminescent material and a light emitting device comprising the luminescent material. The nitride luminescent material recited in the present disclosure includes an inorganic compound with the structural composition R.sub.wQ.sub.xSi.sub.yN.sub.z, the excitation wavelength of the luminescent material is between 300-650 nm, and the emission main peak of the NIR light region is broadband emission between 900-1100 nm; the excitation wavelength of the luminescent material is relatively broad and capable of excellent absorption of ultraviolet visible light, and has more intensive NIR emission as compared with NIR organic luminescent materials and inorganic luminescent materials of other systems, so it is an ideal application material for NIR devices.
Compositions and methods relating to molecular cerium-oxide nanoclusters
Described herein are compositions and methods relating to molecular cerium-oxide nanoclusters. In an aspect, described herein are methods of synthesizing molecular cerium-oxide nanocluster compositions and compositions thereof. In an aspect, described herein are methods of scavenging reactive oxygen species utilizing molecular cerium-oxide nanoclusters as described herein. Also described herein are pharmaceutical compositions and methods of use. Pharmaceutical compositions as described herein can comprise a therapeutically effective amount of a compound (such as a composition comprising one or more molecular cerium-oxide nanoclusters), or a pharmaceutically acceptable salt of the compound, and a pharmaceutically acceptable carrier. Methods of treating oxidative stress are also described herein, comprising administering pharmaceutical compositions as described herein to a subject in need thereof. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present disclosure.
Compositions and methods relating to molecular cerium-oxide nanoclusters
Described herein are compositions and methods relating to molecular cerium-oxide nanoclusters. In an aspect, described herein are methods of synthesizing molecular cerium-oxide nanocluster compositions and compositions thereof. In an aspect, described herein are methods of scavenging reactive oxygen species utilizing molecular cerium-oxide nanoclusters as described herein. Also described herein are pharmaceutical compositions and methods of use. Pharmaceutical compositions as described herein can comprise a therapeutically effective amount of a compound (such as a composition comprising one or more molecular cerium-oxide nanoclusters), or a pharmaceutically acceptable salt of the compound, and a pharmaceutically acceptable carrier. Methods of treating oxidative stress are also described herein, comprising administering pharmaceutical compositions as described herein to a subject in need thereof. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present disclosure.
COMPOSITIONS BASED ON YTTRIUM, CERIUM AND AN ORGANIC COMPOUND, AND STOP-OFF USE THEREOF
The present invention relates to a composition based on yttrium oxide, on a cerium-based compound and on an organic compound and its use in the field of welding as stop-off product. The composition comprises, in an aqueous medium: yttrium oxide particles; particles of a cerium-based compound: which is cerium oxide; or which is prepared by the process consisting in causing a colloidal dispersion D, which is obtained by the neutralization of an aqueous cerium nitrate solution by a basic aqueous solution, to undergo heating; an organic compound chosen from the group formed by polyvinylpyrrolidone, polyvinyl alcohol, carboxymethyl cellulose and hydroxyethyl cellulose.
PHOSPHOR POWDER AND LIGHT-EMITTING DEVICE
A phosphor powder contains an EU-activated β-type sialon phosphor particles. When a median diameter in the phosphor powder having not been subjected to an ultrasonic homogenizer treatment is set as D1 and a median diameter in the phosphor powder having been subjected to an ultrasonic homogenizer treatment is set as D2, 1.05≤D1/D2≤1.70. A dispersion liquid in which 30 mg of the phosphor powder is uniformly dispersed in 100 ml of a 0.2% concentration of a sodium hexametaphosphate aqueous solution is added to a columnar container of which a bottom surface has an inner diameter of 5.5 cm. Then, the dispersion liquid is irradiated with ultrasonic waves for 3 minutes at a frequency of 19.5 kHz, and an output of 150 W, in a state where a cylindrical tip, which has an outer diameter of 20 mm, of an ultrasonic homogenizer is immersed in the dispersion liquid in ≥1.0 cm.
PHOSPHOR POWDER AND LIGHT-EMITTING DEVICE
A phosphor powder contains an EU-activated β-type sialon phosphor particles. When a median diameter in the phosphor powder having not been subjected to an ultrasonic homogenizer treatment is set as D1 and a median diameter in the phosphor powder having been subjected to an ultrasonic homogenizer treatment is set as D2, 1.05≤D1/D2≤1.70. A dispersion liquid in which 30 mg of the phosphor powder is uniformly dispersed in 100 ml of a 0.2% concentration of a sodium hexametaphosphate aqueous solution is added to a columnar container of which a bottom surface has an inner diameter of 5.5 cm. Then, the dispersion liquid is irradiated with ultrasonic waves for 3 minutes at a frequency of 19.5 kHz, and an output of 150 W, in a state where a cylindrical tip, which has an outer diameter of 20 mm, of an ultrasonic homogenizer is immersed in the dispersion liquid in ≥1.0 cm.